Trial Details

RECRUITING
Basic Information
Clinical ID c62
Identifier NCT07242248
Trial Title A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease|Colitis, Ulcerative|Crohn's Disease
Interventions -
Participant Information
Sponsor Janssen-Cilag Ltd.
City Harrow
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2025-11-17
Primary Completion Date 2029-03-05
Completion Date 2029-03-17